Competitive Problems in the Drug Industry Hearings Ninetieth Congress First S
Competitive Problems in the Drug Industry Hearings Ninetieth Congress First S
United States Congress Senate Select Committee
The book Competitive Problems in the Drug Industry Hearings Ninetieth Congress First S was written by author United States Congress Senate Select Committee Here you can read free online of Competitive Problems in the Drug Industry Hearings Ninetieth Congress First S book, rate and share your impressions in comments. If you don't know what to write, just answer the question: Why is Competitive Problems in the Drug Industry Hearings Ninetieth Congress First S a good or bad book?
What reading level is Competitive Problems in the Drug Industry Hearings Ninetieth Congress First S book?
To quickly assess the difficulty of the text, read a short excerpt:
, "Dicloxacillin, a New Antibiotic: Clinical Studies and Laboratory Comparisons v/ith Oxacillin and Cloxacillin. " Antimicrobial Agents and Chemotherapy, 19C4, pp. 257-262. 3. Naumann, P. And Kempf, E. , "Dicloxacillin, a Ncv/ Acid and Penicillinase Stable Oral Penicillin. " Arzneimittel- Forschung. 15, pp. 139-145. 1965. Drictol Telephone Service: (315) 137-0000. If you have any question relating to the use of DYNAPEN (sodium dicloxa- cillin monohydrate) or any other Bristol product, please ca...ll this number colled. A physician in the Medical Department of Bristol Laboratories will be available to answer your question. Bristol Laboratories Division of Bristol-Myers Co. Syracuse. New York 13201 3702 COMPETITIVE PROBLEMS IN THE DRUG INDUSTRY Dr. MiNCHEW. We instituted recertification of Dynapen as of June 21, 1968. Mr. Chairman, if you have any questions, my associates and I will attempt to answer them. Mr. GoRDOX. Mr. Chairman, may I interrupt here? The subcom- mittee has secured documents taken from the files of the Food and Drug Administration that pertain to this matter, and I ask that they be included in the record at the appropriate place.
User Reviews: